{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-017793","form_type":"8-K/A","ticker":"XTNT","cik":"0001453593","company_name":"Xtant Medical Holdings, Inc.","filed_at":"2023-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.921551+00:00","generated_at":"2026-06-14T23:31:57.710512+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Xtant completes $17M acquisition of Surgalign SPV's Coflex/CoFix product lines","bullets":["Purchase price $17M in cash; funded with cash on hand and $5M from existing term loan.","Surgalign SPV 2021 revenue $17.8M, revenues in excess of direct expenses $8.0M.","Pro forma 2021 net income $0.4M vs Xtant standalone net loss $4.8M; accretive.","Acquired Coflex/CoFix FDA-approved for lumbar spinal stenosis, minimally invasive.","Transaction closed Feb 28, 2023; abbreviated financials filed May 16, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-017793","json":"https://secwatch.observer/filing/0001493152-23-017793.json","markdown":"https://secwatch.observer/filing/0001493152-23-017793.md","text":"https://secwatch.observer/filing/0001493152-23-017793.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1453593/000149315223017793/0001493152-23-017793-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1453593/000149315223017793/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T23:31:57.710512+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}